Article Information
History
- April 16, 2021.
Article Versions
- Version 1 (April 15, 2021 - 09:37).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Georgios Renieris1,
- Eleni Karakike1,
- Theologia Gkavogianni1,
- Dionysia- Eirini Droggiti1,
- Dionysios Kafousopoulos1,
- Mihai G. Netea2,3,
- Jesper Eugen-Olsen4,
- John Simard5 and
- Evangelos J. Giamarellos-Bourboulis1,*
- 14th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, 124 62 Athens, Greece
- 2Immunology and Metabolism, Life & Medical Sciences Institute, University of Bonn, 53115 Bonn, Germany
- 3Department of Internal Medicine and Center for Infectious Diseases, Radboud University, 6500 Nijmegen, the Netherlands
- 4Department of Clinical Research, Copenhagen University Hospital Hvidovre, 2650 Hvidovre, Denmark
- 5XBiotech, 78744 Austin, Texas, USA
- ↵*Correspondence:
E. J. Giamarellos-Bourboulis, MD, PhD, 4th Department of Internal Medicine, ATTIKON University General Hospital, 1 Rimini Street 124 62, Athens, Greece, Tel: +30 210 58 31 994/ Fax: +30 210 53 26 446, E-mail: egiamarel{at}med.uoa.gr
Posted April 16, 2021.
IL-1 Mediates Tissue Specific Inflammation and Severe Respiratory Failure In Covid-19: Clinical And Experimental Evidence
